HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype

Rajeev Malhotra1,2, Andreas C Mauer3, Christian L Lino Cardenas3,4

  • 1Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. rmalhotra@mgh.harvard.edu.

Nature Genetics
|October 30, 2019
PubMed

Insights

Researchers identified genetic links to abdominal aortic calcification, discovering HDAC9 as a key factor. This finding offers new insights into vascular calcification and cardiovascular event prediction.

Area of Science:

  • Genetics
  • Cardiovascular Science
  • Vascular Biology

Background:

  • Aortic calcification is a significant predictor of cardiovascular events.
  • Understanding the genetic basis of aortic calcification is crucial for risk assessment.

Purpose of the Study:

  • To identify single nucleotide polymorphisms (SNPs) associated with abdominal aortic calcification (AAC) and descending thoracic aortic calcification (DTAC).
  • To investigate the role of identified genes in vascular calcification.

Main Methods:

  • Genome-wide association meta-analysis of AAC (n=9,417) and DTAC (n=8,422).
  • In vitro studies using human aortic smooth muscle cells to assess HDAC9 expression and function.
  • In vivo studies using matrix Gla protein-deficient mice lacking HDAC9.

Main Results:

  • Two genetic loci, HDAC9 and RAP1GAP, were significantly associated with AAC.
  • No SNPs reached genome-wide significance for DTAC.
  • Increased HDAC9 expression promoted calcification and reduced contractility in human aortic smooth muscle cells.
  • HDAC9 inhibition reversed these effects.
  • Mice lacking HDAC9 showed a 40% reduction in aortic calcification and improved survival.

Conclusions:

  • This study identifies HDAC9 as the first genetic risk locus for abdominal aortic calcification.
  • HDAC9 plays a novel role in the development of vascular calcification.
  • Findings provide a translational link between genetics and vascular calcification, impacting cardiovascular event prediction.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
325
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
335